A carregar...

Cost burden and net monetary benefit loss of neonatal hypoglycaemia

BACKGROUND: Neonatal hypoglycaemia is a common but treatable metabolic disorder that affects newborn infants and which, if not identified and treated adequately, may result in neurological sequelae that persist for the lifetime of the patient. The long-term financial and quality-of-life burden of ne...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Health Serv Res
Main Authors: Glasgow, Matthew J., Edlin, Richard, Harding, Jane E.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7863541/
https://ncbi.nlm.nih.gov/pubmed/33546675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-021-06098-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!